Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
GRAL
GRAL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest GRAL ETF News Today | Earnings, Events & Price Alerts
GRAL News
Following Grail's Study Setback, What Remains for Cancer Blood Screening?
5d ago
Barron's
Grail Stock Surges Over 16% Amid Optimism for Future Developments
Feb 24 2026
Fool
Grail Shares Plunge 50% Amid Clinical Trial Setback
Feb 23 2026
Fool
Grail Stock Plummets 16% Amid Trial Failure
Feb 23 2026
Fool
Baker Bros. Advisors Increases GRAIL Stake by 455,208 Shares
Feb 23 2026
Fool
GRAIL Inc. Shares Drop After NHS-Galleri Trial Results
Feb 23 2026
Benzinga
GRAIL, Inc. Under Investigation for Securities Law Violations
Feb 20 2026
Globenewswire
Grail Stock Plummets 50% Following Trial Failure
Feb 20 2026
Fool
GRAIL Shares Plummet After Clinical Trial Failure
Feb 20 2026
seekingalpha
Midday Market Moves: Retailers Rally Post-Tariff Ruling
Feb 20 2026
CNBC
U.S. Stocks Rise, Nasdaq Gains Over 200 Points
Feb 20 2026
Benzinga
Supreme Court Rules Trump's Tariffs Invalid, Sparks Market Rally
Feb 20 2026
Benzinga
U.S. Stocks Rise in Morning Trade Amid Slowing Economic Growth
Feb 20 2026
Benzinga
Grail Inc. Price Targets Cut Amid Trial Disappointment
Feb 20 2026
stocktwits
GRAIL Reports Q4 Earnings Beat Expectations
Feb 20 2026
seekingalpha
Grail Announces NHS-Galleri Trial Topline Results
Feb 20 2026
seekingalpha
Show More News
